Stockreport

Kyverna Therapeutics to Participate in Upcoming March Investor Conferences

Kyverna Therapeutics, Inc.  (KYTX) 
PDF EMERYVILLE, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a clinical-stage biopharmaceutical company developing cell therapies [Read more]